Evidence map›Paper›PMID 37264375›Full record

ArticleBMC public health2023

Community based multi-disease health screening as an opportunity for early detection of HIV cases and linking them to care.

Christopher Z-Y Abana, Dennis K Kushitor, Theodore W Asigbee, Prince K Parbie, Koichi Ishikawa, Hiroshi Kiyono, Taketoshi Mizutani, Samuel Siaw, Sampson B Ofori, Gifty Addo-Tetebo and 7 more

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Christopher Z-Y AbanaVirology Department, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Accra, Ghana.
Dennis K KushitorVirology Department, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Accra, Ghana.
Theodore W AsigbeeVirology Department, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Accra, Ghana.
Prince K ParbieAIDS Research Center, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
Koichi IshikawaAIDS Research Center, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
Hiroshi KiyonoInstitute of Medical Sciences, The University of Tokyo, Tokyo, Japan.
Taketoshi MizutaniInstitute of Medical Sciences, The University of Tokyo, Tokyo, Japan.
Samuel SiawEastern Regional Hospital, Koforidua, Ghana.
Sampson B OforiEastern Regional Hospital, Koforidua, Ghana.
Gifty Addo-TeteboEastern Regional Hospital, Koforidua, Ghana.
Maclean R D AnsongVirology Department, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Accra, Ghana.
Marion WilliamsEastern Regional Hospital, Koforidua, Ghana.
Samuel MortonEastern Regional Hospital, Koforidua, Ghana.
George DanquahEastern Regional Hospital, Koforidua, Ghana.
Tetsuro MatanoAIDS Research Center, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
William K AmpofoVirology Department, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Accra, Ghana.
Evelyn Y BonneyVirology Department, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Accra, Ghana. ebonney@noguchi.ug.edu.gh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 95-95-95 UNAIDS global strategy was adapted to end the AIDS epidemic by 2030. The target is based on the premise that early detection of HIV-infected persons and linking them to treatment regardless of their CD4 counts will lead to sustained viral suppression. HIV testing strategies to increase uptake of testing in Western and Central Africa remain inadequate. Hence, a high proportion of people living with HIV in this region do not know their status. This report describes the implementation of a community based multi-disease health screening (also known as "Know Your Status" -KYS), as part of basic science research, in a way that contributed to achieving public health goals.

methodsA community based multi-disease health screening was conducted in 7 communities within the Eastern region of Ghana between November 2017 and April 2018, to recruit and match HIV seronegative persons to HIV seropositive persons in a case-control HIV gut microbiota study. Health assessments included blood pressure, body mass index, blood sugar, Hepatitis B virus, syphilis, and HIV testing for those who consented. HIV seronegative participants who consented were consecutively enrolled in an ongoing HIV gut microbiota case-control study. Descriptive statistics (percentages) were used to analyze data.

resultsOut of 738 people screened during the exercise, 700 consented to HIV testing and 23 (3%) were HIV positive. Hepatitis B virus infection was detected in 4% (33/738) and Syphilis in 2% (17/738). Co-infection of HIV and HBV was detected in 4 persons. The HIV prevalence of 3% found in these communities is higher than both the national prevalence of 1.7% and the Eastern Regional prevalence of 2.7 in 2018.

conclusionCommunity based multi-disease health screening, such as the one undertaken in our study could be critical for identifying HIV infected persons from the community and linking them to care. In the case of HIV, it will greatly contribute to achieving the first two 95s and working towards ending AIDS by 2030.

Indexed as

HIV InfectionsMass ScreeningAdultCoinfectionCommunity Health ServicesContinuity of Patient CareCross-Sectional StudiesEarly DiagnosisFemaleGhanaHepatitis BHIV TestingHumansMalePrevalenceSyphilisCommunity-basedHIVKnow your statusMulti-disease screening

Identifiers

PMID37264375
PMCPMC10236736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.